Akzo Nobel N.V.
AKZOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,703,512 | $12,396,204 | $10,662,517 | $17,151,833 |
| - Cash | $1,302,000 | $1,513,000 | $1,450,000 | $1,152,000 |
| + Debt | $5,368,000 | $5,563,000 | $5,875,000 | $3,550,000 |
| Enterprise Value | $13,769,512 | $16,446,204 | $15,087,517 | $19,549,833 |
| Revenue | $10,711,000 | $10,668,000 | $10,846,000 | $9,587,000 |
| % Growth | 0.4% | -1.6% | 13.1% | – |
| Gross Profit | $4,337,000 | $4,234,000 | $3,923,000 | $3,855,000 |
| % Margin | 40.5% | 39.7% | 36.2% | 40.2% |
| EBITDA | $1,399,000 | $1,320,000 | $1,070,000 | $1,530,000 |
| % Margin | 13.1% | 12.4% | 9.9% | 16% |
| Net Income | $542,000 | $442,000 | $352,000 | $829,000 |
| % Margin | 5.1% | 4.1% | 3.2% | 8.6% |
| EPS Diluted | 3.16 | 2.58 | 2.01 | 4.46 |
| % Growth | 22.5% | 28.4% | -54.9% | – |
| Operating Cash Flow | $673,000 | $1,126,000 | $263,000 | $605,000 |
| Capital Expenditures | -$306,000 | -$286,000 | -$292,000 | -$288,000 |
| Free Cash Flow | $367,000 | $840,000 | -$29,000 | $317,000 |